MarketInOut Stock Screener Log In | Sign Up

Estrella Immunopharma Inc Wt

NASDAQ • Healthcare • Biotechnology • Quote as of 10/28/2026
Estrella Immunopharma Inc Wt stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization20.01 mln
Float9.10 mln
Earnings Date11/12/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

15 / 100
Significantly lagging

ROE

122
Extraordinary

ROA

-330
Deeply negative

Business Description

Estrella Immunopharma Inc. is a California-based company working to develop new cancer treatments that use the body's own immune cells to fight both blood cancers and solid tumors. Its two main programs target diffuse large B-cell lymphoma and acute lymphocytic leukemia, with both still in early research stages. The company is also partnering with Imugene Limited to combine their respective technologies in pursuit of more effective solid tumor therapies.

Key Fundamentals

EPS-0.25
ROE122
ROIC-586
ROA-330
EBITDA, mln-9.79
EV / EBITDA-1.98
EV / EBIT-1.98

Quote Details

Last 0.07
Change -0.0099 (-12.39%)
Open 0.07
Volume 12,100
Turnover 847
Average Volume 3,215.86

Financial Strength

Piotroski F-Score 3 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 33.08% 99 / 100   
1 Month -30% 11 / 100   
2 Months 13.64% 86 / 100   
6 Months 98.3% 97 / 100   
1 Year 110% 97 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog